Gsk Share Discussion Threads

[alphorn] 23/1/2017 16:33

Agree, any new super-antibiotic would have be used sparingly and therefore would have to be sold at a high price. Not easy, let alone find one.

[essentialinvestor] 23/1/2017 16:32

Trump has also made some worrying comments on US vaccination programmes.

He has appointed a well known vaccine sceptic to review this, a member of the Kennedy
family from memory.

[dr biotech] 23/1/2017 16:30

Part of the problem with developing new antibiotics is their commercial appeal. If we have an anitbiotic of last resort, you don't want to use it a lot to allow the bacteria to gain resistance..

Much needed though. Not sure where the market is heading. Trumps easy answers of lowering tax, spending more on infrastructure and imposing trade tarriffs doesn't sound like it is thought through. I am already concerned that this will be a presidency that runs on rhetoric not facts.

[essentialinvestor] 23/1/2017 16:24

Yes that is the case, however many antibiotic compounds are not on M/R.

It tends to be more common on antibiotics used to treat chronic conditions,
acne etc. Minocycline M/R as one example.

[alphorn] 23/1/2017 16:08

There are other ways to extend IP protection - eg, delivery methods, combos, delayed release methods to name three.

[essentialinvestor] 23/1/2017 16:04

Another small amount.


M, you cynic ).

[minerve] 23/1/2017 15:54

"I hoped there would be an agreement to extend patent duration in developed(not developing) markets to help spark extra commercial interest in research."

We wish. I don't think those in power have any intellect to see that far Essential.

[essentialinvestor] 23/1/2017 15:47

Yes valid observation.

I hoped there would be an agreement to extend patent duration in developed(not developing) markets to help spark extra commercial interest in research.

[philanderer] 23/1/2017 15:41

FTSE100 now back where it ended 2016

[alphorn] 23/1/2017 14:36

Richard Sykes talked about the antibiotic problem around 20 years ago. He saw it coming and that is probably why GSK continued with its research.

[essentialinvestor] 23/1/2017 14:30

Gary thanks. taking things a little easy for a few weeks to get my BP
down, will have a look though.


Read a case on antibiotic resistance over the weekend where 28 different antibiotics were tried and everyone failed, the patient died.

GSK one of the few major pharmas still engaged in antibiotic discovery/research,
for all our sakes we badly need breakthroughs in this area.

[garycook] 23/1/2017 14:25

EI,Have a look at CARD,near a 52 week low of 232,and yielding nearly 10% with the Special Dividend.

[essentialinvestor] 23/1/2017 14:18

Nicely done on PHTM, was very tempted at 1.43 but passed.

Under 1524 my next level, also depends on what else is available/interesting.

[ny boy] 23/1/2017 14:13

Added a few more @ 1530p for the pension fund

[essentialinvestor] 23/1/2017 13:28

Yes agree, if the UKX heads 5/6% it makes that more likely.

[garycook] 23/1/2017 13:19

EI,If the UKX falls further,then so will GSK,also with the USD dropping today,makes it worse.I hope I am wrong,but we will see in due course.

[essentialinvestor] 23/1/2017 12:13

With the UKX around this level 1450/60 may be unlikely without some
unexpectedly poor news imv.

[philanderer] 23/1/2017 10:55

23rd jan Berenberg hold tp 1850p cut from 1885p

[garycook] 23/1/2017 09:14

GSK, Will Gap fill back to Dec 5 Low around 1450/60.

[ny boy] 20/1/2017 11:32

Market has allowed me to add some more stock at lower prices tks!

[philanderer] 20/1/2017 09:50

20th jan Jefferies buy tp 1780p up from 1750p

[mj19] 20/1/2017 09:35

This shouldn't follow the price of sterling it's well under valued at this price

[philanderer] 19/1/2017 09:53

19th jan Deutsche hold tp 1800p
19th jan Liberum buy tp 1900p

[tradermichael] 19/1/2017 09:22

IN at 1562.25 (with dividend cash) ..... ;0)

[philanderer] 17/1/2017 14:25

Post May speech..

"The pound's on course for its biggest one-day rise against the dollar since 2008"